Table of Content

1 Study Coverage
1.1 Humira Biosimilar Product Introduction
1.2 Market by Type
1.2.1 Global Humira Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034
1.2.2 Syringe
1.2.3 Pen
1.3 Market by Application
1.3.1 Global Humira Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034
1.3.2 Ankylosing Spondylitis
1.3.3 Rheumatoid Arthritis
1.3.4 Crohn’s Disease
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Humira Biosimilar Sales Estimates and Forecasts 2018-2034
2.2 Global Humira Biosimilar Revenue by Region
2.2.1 Global Humira Biosimilar Revenue by Region: 2018 VS 2024 VS 2034
2.2.2 Global Humira Biosimilar Revenue by Region (2018-2023)
2.2.3 Global Humira Biosimilar Revenue by Region (2024-2034)
2.2.4 Global Humira Biosimilar Revenue Market Share by Region (2018-2034)
2.3 Global Humira Biosimilar Sales Estimates and Forecasts 2018-2034
2.4 Global Humira Biosimilar Sales by Region
2.4.1 Global Humira Biosimilar Sales by Region: 2018 VS 2024 VS 2034
2.4.2 Global Humira Biosimilar Sales by Region (2018-2023)
2.4.3 Global Humira Biosimilar Sales by Region (2024-2034)
2.4.4 Global Humira Biosimilar Sales Market Share by Region (2018-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Humira Biosimilar Sales by Manufacturers
3.1.1 Global Humira Biosimilar Sales by Manufacturers (2018-2023)
3.1.2 Global Humira Biosimilar Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Humira Biosimilar in 2024
3.2 Global Humira Biosimilar Revenue by Manufacturers
3.2.1 Global Humira Biosimilar Revenue by Manufacturers (2018-2023)
3.2.2 Global Humira Biosimilar Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Humira Biosimilar Revenue in 2024
3.3 Global Key Players of Humira Biosimilar, Industry Ranking, 2021 VS 2024 VS 2023
3.4 Global Humira Biosimilar Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Humira Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Humira Biosimilar, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Humira Biosimilar, Product Offered and Application
3.8 Global Key Manufacturers of Humira Biosimilar, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Humira Biosimilar Sales by Type
4.1.1 Global Humira Biosimilar Historical Sales by Type (2018-2023)
4.1.2 Global Humira Biosimilar Forecasted Sales by Type (2024-2034)
4.1.3 Global Humira Biosimilar Sales Market Share by Type (2018-2034)
4.2 Global Humira Biosimilar Revenue by Type
4.2.1 Global Humira Biosimilar Historical Revenue by Type (2018-2023)
4.2.2 Global Humira Biosimilar Forecasted Revenue by Type (2024-2034)
4.2.3 Global Humira Biosimilar Revenue Market Share by Type (2018-2034)
4.3 Global Humira Biosimilar Price by Type
4.3.1 Global Humira Biosimilar Price by Type (2018-2023)
4.3.2 Global Humira Biosimilar Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Humira Biosimilar Sales by Application
5.1.1 Global Humira Biosimilar Historical Sales by Application (2018-2023)
5.1.2 Global Humira Biosimilar Forecasted Sales by Application (2024-2034)
5.1.3 Global Humira Biosimilar Sales Market Share by Application (2018-2034)
5.2 Global Humira Biosimilar Revenue by Application
5.2.1 Global Humira Biosimilar Historical Revenue by Application (2018-2023)
5.2.2 Global Humira Biosimilar Forecasted Revenue by Application (2024-2034)
5.2.3 Global Humira Biosimilar Revenue Market Share by Application (2018-2034)
5.3 Global Humira Biosimilar Price by Application
5.3.1 Global Humira Biosimilar Price by Application (2018-2023)
5.3.2 Global Humira Biosimilar Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Humira Biosimilar Market Size by Type
6.1.1 US & Canada Humira Biosimilar Sales by Type (2018-2034)
6.1.2 US & Canada Humira Biosimilar Revenue by Type (2018-2034)
6.2 US & Canada Humira Biosimilar Market Size by Application
6.2.1 US & Canada Humira Biosimilar Sales by Application (2018-2034)
6.2.2 US & Canada Humira Biosimilar Revenue by Application (2018-2034)
6.3 US & Canada Humira Biosimilar Market Size by Country
6.3.1 US & Canada Humira Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
6.3.2 US & Canada Humira Biosimilar Sales by Country (2018-2034)
6.3.3 US & Canada Humira Biosimilar Revenue by Country (2018-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Humira Biosimilar Market Size by Type
7.1.1 Europe Humira Biosimilar Sales by Type (2018-2034)
7.1.2 Europe Humira Biosimilar Revenue by Type (2018-2034)
7.2 Europe Humira Biosimilar Market Size by Application
7.2.1 Europe Humira Biosimilar Sales by Application (2018-2034)
7.2.2 Europe Humira Biosimilar Revenue by Application (2018-2034)
7.3 Europe Humira Biosimilar Market Size by Country
7.3.1 Europe Humira Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
7.3.2 Europe Humira Biosimilar Sales by Country (2018-2034)
7.3.3 Europe Humira Biosimilar Revenue by Country (2018-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Humira Biosimilar Market Size
8.1.1 China Humira Biosimilar Sales (2018-2034)
8.1.2 China Humira Biosimilar Revenue (2018-2034)
8.2 China Humira Biosimilar Market Size by Application
8.2.1 China Humira Biosimilar Sales by Application (2018-2034)
8.2.2 China Humira Biosimilar Revenue by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Humira Biosimilar Market Size by Type
9.1.1 Asia Humira Biosimilar Sales by Type (2018-2034)
9.1.2 Asia Humira Biosimilar Revenue by Type (2018-2034)
9.2 Asia Humira Biosimilar Market Size by Application
9.2.1 Asia Humira Biosimilar Sales by Application (2018-2034)
9.2.2 Asia Humira Biosimilar Revenue by Application (2018-2034)
9.3 Asia Humira Biosimilar Sales by Region
9.3.1 Asia Humira Biosimilar Revenue by Region: 2018 VS 2024 VS 2034
9.3.2 Asia Humira Biosimilar Revenue by Region (2018-2034)
9.3.3 Asia Humira Biosimilar Sales by Region (2018-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Humira Biosimilar Market Size by Type
10.1.1 Middle East, Africa and Latin America Humira Biosimilar Sales by Type (2018-2034)
10.1.2 Middle East, Africa and Latin America Humira Biosimilar Revenue by Type (2018-2034)
10.2 Middle East, Africa and Latin America Humira Biosimilar Market Size by Application
10.2.1 Middle East, Africa and Latin America Humira Biosimilar Sales by Application (2018-2034)
10.2.2 Middle East, Africa and Latin America Humira Biosimilar Revenue by Application (2018-2034)
10.3 Middle East, Africa and Latin America Humira Biosimilar Sales by Country
10.3.1 Middle East, Africa and Latin America Humira Biosimilar Revenue by Country: 2018 VS 2024 VS 2034
10.3.2 Middle East, Africa and Latin America Humira Biosimilar Revenue by Country (2018-2034)
10.3.3 Middle East, Africa and Latin America Humira Biosimilar Sales by Country (2018-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Cadila Healthcare
11.1.1 Cadila Healthcare Company Information
11.1.2 Cadila Healthcare Overview
11.1.3 Cadila Healthcare Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Cadila Healthcare Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Cadila Healthcare Recent Developments
11.2 Torrent Pharmaceuticals
11.2.1 Torrent Pharmaceuticals Company Information
11.2.2 Torrent Pharmaceuticals Overview
11.2.3 Torrent Pharmaceuticals Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Torrent Pharmaceuticals Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Torrent Pharmaceuticals Recent Developments
11.3 Amgen
11.3.1 Amgen Company Information
11.3.2 Amgen Overview
11.3.3 Amgen Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Amgen Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Amgen Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Boehringer Ingelheim Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Overview
11.5.3 Novartis Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Novartis Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novartis Recent Developments
11.6 Samsung Bioepis
11.6.1 Samsung Bioepis Company Information
11.6.2 Samsung Bioepis Overview
11.6.3 Samsung Bioepis Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Samsung Bioepis Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Samsung Bioepis Recent Developments
11.7 Viatris
11.7.1 Viatris Company Information
11.7.2 Viatris Overview
11.7.3 Viatris Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Viatris Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Viatris Recent Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Overview
11.8.3 Pfizer Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Pfizer Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Pfizer Recent Developments
11.9 Fresenius Kabi
11.9.1 Fresenius Kabi Company Information
11.9.2 Fresenius Kabi Overview
11.9.3 Fresenius Kabi Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Fresenius Kabi Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Fresenius Kabi Recent Developments
11.10 Coherus
11.10.1 Coherus Company Information
11.10.2 Coherus Overview
11.10.3 Coherus Humira Biosimilar Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Coherus Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Coherus Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Humira Biosimilar Industry Chain Analysis
12.2 Humira Biosimilar Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Humira Biosimilar Production Mode & Process
12.4 Humira Biosimilar Sales and Marketing
12.4.1 Humira Biosimilar Sales Channels
12.4.2 Humira Biosimilar Distributors
12.5 Humira Biosimilar Customers
13 Market Dynamics
13.1 Humira Biosimilar Industry Trends
13.2 Humira Biosimilar Market Drivers
13.3 Humira Biosimilar Market Challenges
13.4 Humira Biosimilar Market Restraints
14 Key Findings in The Global Humira Biosimilar Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Humira Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Syringe
Table 3. Major Manufacturers of Pen
Table 4. Global Humira Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Table 5. Global Humira Biosimilar Revenue Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 6. Global Humira Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Humira Biosimilar Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Humira Biosimilar Revenue Market Share by Region (2018-2023)
Table 9. Global Humira Biosimilar Revenue Market Share by Region (2024-2034)
Table 10. Global Humira Biosimilar Sales Grow Rate (CAGR) by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 11. Global Humira Biosimilar Sales by Region (2018-2023) & (K Units)
Table 12. Global Humira Biosimilar Sales by Region (2024-2034) & (K Units)
Table 13. Global Humira Biosimilar Sales Market Share by Region (2018-2023)
Table 14. Global Humira Biosimilar Sales Market Share by Region (2024-2034)
Table 15. Global Humira Biosimilar Sales by Manufacturers (2018-2023) & (K Units)
Table 16. Global Humira Biosimilar Sales Share by Manufacturers (2018-2023)
Table 17. Global Humira Biosimilar Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 18. Global Humira Biosimilar Revenue Share by Manufacturers (2018-2023)
Table 19. Global Key Players of Humira Biosimilar, Industry Ranking, 2021 VS 2024 VS 2023
Table 20. Humira Biosimilar Price by Manufacturers 2018-2023 (US$/Unit)
Table 21. Global Humira Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Humira Biosimilar by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Humira Biosimilar as of 2024)
Table 23. Global Key Manufacturers of Humira Biosimilar, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Humira Biosimilar, Product Offered and Application
Table 25. Global Key Manufacturers of Humira Biosimilar, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 28. Global Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 29. Global Humira Biosimilar Sales Share by Type (2018-2023)
Table 30. Global Humira Biosimilar Sales Share by Type (2024-2034)
Table 31. Global Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 32. Global Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Humira Biosimilar Revenue Share by Type (2018-2023)
Table 34. Global Humira Biosimilar Revenue Share by Type (2024-2034)
Table 35. Humira Biosimilar Price by Type (2018-2023) & (US$/Unit)
Table 36. Global Humira Biosimilar Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 38. Global Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 39. Global Humira Biosimilar Sales Share by Application (2018-2023)
Table 40. Global Humira Biosimilar Sales Share by Application (2024-2034)
Table 41. Global Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 42. Global Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Humira Biosimilar Revenue Share by Application (2018-2023)
Table 44. Global Humira Biosimilar Revenue Share by Application (2024-2034)
Table 45. Humira Biosimilar Price by Application (2018-2023) & (US$/Unit)
Table 46. Global Humira Biosimilar Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 48. US & Canada Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 50. US & Canada Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 52. US & Canada Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 54. US & Canada Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Humira Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 56. US & Canada Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 57. US & Canada Humira Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 59. US & Canada Humira Biosimilar Sales by Country (2024-2034) & (K Units)
Table 60. Europe Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 61. Europe Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 62. Europe Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 63. Europe Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 65. Europe Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 66. Europe Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 67. Europe Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Humira Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 69. Europe Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 70. Europe Humira Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 72. Europe Humira Biosimilar Sales by Country (2024-2034) & (K Units)
Table 73. China Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 74. China Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 75. China Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 76. China Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 78. China Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 79. China Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 80. China Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 82. Asia Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 83. Asia Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 84. Asia Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 86. Asia Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 87. Asia Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 88. Asia Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Humira Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 90. Asia Humira Biosimilar Revenue by Region (2018-2023) & (US$ Million)
Table 91. Asia Humira Biosimilar Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Humira Biosimilar Sales by Region (2018-2023) & (K Units)
Table 93. Asia Humira Biosimilar Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Humira Biosimilar Sales by Type (2018-2023) & (K Units)
Table 95. Middle East, Africa and Latin America Humira Biosimilar Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Humira Biosimilar Revenue by Type (2018-2023) & (US$ Million)
Table 97. Middle East, Africa and Latin America Humira Biosimilar Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Humira Biosimilar Sales by Application (2018-2023) & (K Units)
Table 99. Middle East, Africa and Latin America Humira Biosimilar Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Humira Biosimilar Revenue by Application (2018-2023) & (US$ Million)
Table 101. Middle East, Africa and Latin America Humira Biosimilar Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Humira Biosimilar Revenue Grow Rate (CAGR) by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Humira Biosimilar Revenue by Country (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Humira Biosimilar Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Humira Biosimilar Sales by Country (2018-2023) & (K Units)
Table 106. Middle East, Africa and Latin America Humira Biosimilar Sales by Country (2024-2034) & (K Units)
Table 107. Cadila Healthcare Company Information
Table 108. Cadila Healthcare Description and Major Businesses
Table 109. Cadila Healthcare Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Cadila Healthcare Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Cadila Healthcare Recent Developments
Table 112. Torrent Pharmaceuticals Company Information
Table 113. Torrent Pharmaceuticals Description and Major Businesses
Table 114. Torrent Pharmaceuticals Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Torrent Pharmaceuticals Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Torrent Pharmaceuticals Recent Developments
Table 117. Amgen Company Information
Table 118. Amgen Description and Major Businesses
Table 119. Amgen Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Amgen Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Amgen Recent Developments
Table 122. Boehringer Ingelheim Company Information
Table 123. Boehringer Ingelheim Description and Major Businesses
Table 124. Boehringer Ingelheim Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Boehringer Ingelheim Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer Ingelheim Recent Developments
Table 127. Novartis Company Information
Table 128. Novartis Description and Major Businesses
Table 129. Novartis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Novartis Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Novartis Recent Developments
Table 132. Samsung Bioepis Company Information
Table 133. Samsung Bioepis Description and Major Businesses
Table 134. Samsung Bioepis Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Samsung Bioepis Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Samsung Bioepis Recent Developments
Table 137. Viatris Company Information
Table 138. Viatris Description and Major Businesses
Table 139. Viatris Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Viatris Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Viatris Recent Developments
Table 142. Pfizer Company Information
Table 143. Pfizer Description and Major Businesses
Table 144. Pfizer Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Pfizer Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Pfizer Recent Developments
Table 147. Fresenius Kabi Company Information
Table 148. Fresenius Kabi Description and Major Businesses
Table 149. Fresenius Kabi Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Fresenius Kabi Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Fresenius Kabi Recent Developments
Table 152. Coherus Company Information
Table 153. Coherus Description and Major Businesses
Table 154. Coherus Humira Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. Coherus Humira Biosimilar Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Coherus Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Humira Biosimilar Distributors List
Table 160. Humira Biosimilar Customers List
Table 161. Humira Biosimilar Market Trends
Table 162. Humira Biosimilar Market Drivers
Table 163. Humira Biosimilar Market Challenges
Table 164. Humira Biosimilar Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Humira Biosimilar Product Picture
Figure 2. Global Humira Biosimilar Market Size Growth Rate by Type, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Humira Biosimilar Market Share by Type in 2024 & 2034
Figure 4. Syringe Product Picture
Figure 5. Pen Product Picture
Figure 6. Global Humira Biosimilar Market Size Growth Rate by Application, 2018 VS 2024 VS 2034 (US$ Million)
Figure 7. Global Humira Biosimilar Market Share by Application in 2024 & 2034
Figure 8. Ankylosing Spondylitis
Figure 9. Rheumatoid Arthritis
Figure 10. Crohn’s Disease
Figure 11. Other
Figure 12. Humira Biosimilar Report Years Considered
Figure 13. Global Humira Biosimilar Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Humira Biosimilar Revenue 2018-2034 (US$ Million)
Figure 15. Global Humira Biosimilar Revenue Market Share by Region in Percentage: 2024 Versus 2034
Figure 16. Global Humira Biosimilar Revenue Market Share by Region (2018-2034)
Figure 17. Global Humira Biosimilar Sales 2018-2034 ((K Units)
Figure 18. Global Humira Biosimilar Sales Market Share by Region (2018-2034)
Figure 19. US & Canada Humira Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 20. US & Canada Humira Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Humira Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 22. Europe Humira Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Humira Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 24. China Humira Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 25. Asia (excluding China) Humira Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 26. Asia (excluding China) Humira Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Humira Biosimilar Sales YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Humira Biosimilar Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Humira Biosimilar Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2024
Figure 30. The Top 5 and 10 Largest Manufacturers of Humira Biosimilar in the World: Market Share by Humira Biosimilar Revenue in 2024
Figure 31. Global Humira Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 32. Global Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 33. Global Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 34. Global Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 35. Global Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 36. US & Canada Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 37. US & Canada Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 38. US & Canada Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 39. US & Canada Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 40. US & Canada Humira Biosimilar Revenue Share by Country (2018-2034)
Figure 41. US & Canada Humira Biosimilar Sales Share by Country (2018-2034)
Figure 42. U.S. Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 43. Canada Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 44. Europe Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 45. Europe Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 46. Europe Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 47. Europe Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 48. Europe Humira Biosimilar Revenue Share by Country (2018-2034)
Figure 49. Europe Humira Biosimilar Sales Share by Country (2018-2034)
Figure 50. Germany Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 51. France Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 52. U.K. Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 53. Italy Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 54. Russia Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 55. China Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 56. China Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 57. China Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 58. China Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 59. Asia Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 60. Asia Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 61. Asia Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 62. Asia Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 63. Asia Humira Biosimilar Revenue Share by Region (2018-2034)
Figure 64. Asia Humira Biosimilar Sales Share by Region (2018-2034)
Figure 65. Japan Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 66. South Korea Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 67. China Taiwan Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 68. Southeast Asia Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 69. India Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Humira Biosimilar Sales Market Share by Type (2018-2034)
Figure 71. Middle East, Africa and Latin America Humira Biosimilar Revenue Market Share by Type (2018-2034)
Figure 72. Middle East, Africa and Latin America Humira Biosimilar Sales Market Share by Application (2018-2034)
Figure 73. Middle East, Africa and Latin America Humira Biosimilar Revenue Market Share by Application (2018-2034)
Figure 74. Middle East, Africa and Latin America Humira Biosimilar Revenue Share by Country (2018-2034)
Figure 75. Middle East, Africa and Latin America Humira Biosimilar Sales Share by Country (2018-2034)
Figure 76. Brazil Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 77. Mexico Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 78. Turkey Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 79. Israel Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 80. GCC Countries Humira Biosimilar Revenue (2018-2034) & (US$ Million)
Figure 81. Humira Biosimilar Value Chain
Figure 82. Humira Biosimilar Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed